2 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Malignant Neoplasm: new trials by email Literature Review of Malignant Neoplasm trials Research Report on Malignant Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents OR2805, Cemiplimab, Docetaxel - Cancer, Tumor, Solid | Phase 1 / Phase 2 | Unknown | OncoResponse, Inc. | 172 | 2021-09-09 | 2023-11-02 |
| High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer Oxygen Therapy, Quality-of-Life Assessment, Questionnaire Administration - Dyspnea, Malignant Neoplasm | Phase 2 | Unknown | M.D. Anderson Cancer Center | 74 | 2015-03-17 | 2022-12-07 |
Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Dyspnea (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1)
Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1)
Docetaxel (1) · Oxygen (1) · Respiratory Therapy (1) · cemiplimab (1)
M.D. Anderson Cancer Center (1) · OncoResponse, Inc. (1)
United States (2)
David Hui (1)